Arch Therapeutics (ARTH) Competitor Comparison
We are evaluating the key criteria listed to compare Arch Therapeutics (ARTH) against its competitors in the Biotechnology industry.
Market Capitalization
344 / 368Gross Profits
152 / 278Total Revenue
277 / 300EBITDA
39 / 337Free Cashflow
43 / 352Quick Ratio
357 / 357Earnings per Share
156 / 359Dividend yield
0 / 5Total Cash
358 / 358Performance 3 years
349 / 368Performance 5 years
355 / 368Performance 10 years
328 / 368Linearity 3 years
270 / 368Linearity 5 years
279 / 368Linearity 10 years
132 / 368Total Rank
144 / 368Dividend Rank
9 / 368Valuation Rank
84 / 368Piotroski Rank
224 / 368Muliplier Rank
274 / 368Linearity 3 years - ARTH ranking 270 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.